Search Results - "Suwinski, Rafał"

Pretreatment plasma osteopontin level as a marker of response to curative radiotherapy and hormonal treatment for prostate cancer by Smolska-Ciszewska, Beata, Mrochem-Kwarciak, Jolanta, Karczmarczyk, Katarzyna, Deja, Regina, Suwiński, Rafał

“…•We confirmed the prognostic influence of OPN on survival of prostate cancer patients treated with radiotherapy with 10-year OS rate for group with OPN level…”
Get full text

Mathematical model predicts response to chemotherapy in advanced non-resectable non-small cell lung cancer patients treated with platinum-based doublet by Kozłowska, Emilia, Suwiński, Rafał, Giglok, Monika, Świerniak, Andrzej, Kimmel, Marek

“…We developed a computational platform including machine learning and a mechanistic mathematical model to find the optimal protocol for administration of…”
Get full text

Systemic treatment in patients with malignant pleural mesothelioma - real life experience by Ziółkowska, Barbara, Cybulska-Stopa, Bożena, Papantoniou, Dimitrios, Suwiński, Rafał

“…Malignant pleural mesothelioma (MPM) is a rare, aggressive malignancy of the pleural cavity linked to asbestos exposure. The combination of pemetrexed and…”
Get full text

Randomized clinical trial on accelerated preoperative hyperfractionated radiotherapy versus preoperative hyperfractionated radio-chemotherapy in locally advanced rectal cancer by Idasiak, Adam, Ziółkowska, Barbara, Rajczykowski, Marcin, Galwas, Katarzyna, Dębosz-Suwińska, Iwona, Zeman, Marcin, Mrochem-Kwarciak, Jolanta, Suwiński, Rafał

“…Abstract Objectives The aim of this study was to compare pathological response rates after preoperative hyperfractionated radiotherapy with co-administration…”
Get full text

Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy by Butkiewicz, Dorota, Krześniak, Małgorzata, Gdowicz-Kłosok, Agnieszka, Giglok, Monika, Marszałek-Zeńczak, Małgorzata, Suwiński, Rafał

“…For non-small cell lung cancer (NSCLC), radiotherapy (RT) and platinum-based chemotherapy (CHT) are among the main treatment options. On the other hand,…”
Get full text

Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer by Suwinski, Rafał, Giglok, Monika, Galwas-Kliber, Katarzyna, Idasiak, Adam, Jochymek, Bozena, Deja, Regina, Maslyk, Barbara, Mrochem-Kwarciak, Jolanta, Butkiewicz, Dorota

“…Several studies have documented that blood biomarkers can improve basic prognostic models in radiotherapy and radio-chemotherapy for non-small cell lung…”
Get full text

Detection of circulating HPV16 DNA as a biomarker in the blood of patients with human papillomavirus‐positive oropharyngeal squamous cell carcinoma by Mazurek, Agnieszka M., Rutkowski, Tomasz, Śnietura, Mirosław, Pigłowski, Wojciech, Suwiński, Rafał, Składowski, Krzysztof

“…Background Development of biomarker analysis using the circulating cell‐free DNA (cfDNA) methodology is a challenge for noninvasive cancer diagnosis. In this…”
Get full text

Significance of HPV16 Viral Load Testing in Anal Cancer by Małusecka, Ewa, Chmielik, Ewa, Suwiński, Rafał, Giglok, Monika, Lange, Dariusz, Rutkowski, Tomasz, Mazurek, Agnieszka M.

“…Human papilloma virus (HPV) is highly frequent among patients with anal squamous cell carcinoma, but the viral load (VL) differs between patients. This study…”
Get full text

Common Variants in Osteopontin and CD44 Genes as Predictors of Treatment Outcome in Radiotherapy and Chemoradiotherapy for Non-Small Cell Lung Cancer by Gałecki, Seweryn, Gdowicz-Kłosok, Agnieszka, Deja, Regina, Masłyk, Barbara, Giglok, Monika, Suwiński, Rafał, Butkiewicz, Dorota

“…Osteopontin (OPN)-CD44 signaling plays an important role in promoting tumor progression and metastasis. In cancer, OPN and CD44 overexpression is a marker of…”
Get full text

Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost by Moll, Matthias, Magrowski, Łukasz, Mittlböck, Martina, Heinzl, Harald, Kirisits, Christian, Ciepał, Jakub, Masri, Oliwia, Heilemann, Gerd, Stando, Rafał, Krzysztofiak, Tomasz, Depowska, Gabriela, d'Amico, Andrea, Techmański, Tomasz, Kozub, Anna, Majewski, Wojciech, Suwiński, Rafał, Wojcieszek, Piotr, Sadowski, Jacek, Widder, Joachim, Goldner, Gregor, Miszczyk, Marcin

“…External beam radiotherapy (EBRT) with or without brachytherapy boost (BTB) has not been compared in prospective studies using guideline-recommended radiation…”
Get full text

Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment by Cybulska-Stopa, Bożena, Piejko, Karolina, Ostaszewski, Krzysztof, Dziura, Robert, Galus, Łukasz, Ziółkowska, Barbara, Kempa-Kamińska, Natasza, Ziętek, Marcin, Bal, Wiesław, Kamycka, Agnieszka, Dudzisz-Śledź, Monika, Kubiatowski, Tomasz, Kamińska-Winciorek, Grażyna, Suwiński, Rafał, Mackiewicz, Jacek, Czarnecka, Anna Małgorzata, Rutkowski, Piotr

“…Pembrolizumab and nivolumab (anty-PD-1 antibody) are commonly used for the treatment of melanoma patients. However, their efficacy and safety have never been…”
Get full text

BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma by Cybulska-Stopa, Bożena, Rogala, Paweł, Czarnecka, Anna M., Galus, Łukasz, Dziura, Robert, Rajczykowski, Marcin, Kubiatowski, Tomasz, Wiśniewska, Magdalena, Gęga-Czarnota, Adrianna, Teterycz, Paweł, Ziobro, Marek, Suwiński, Rafał, Mackiewicz, Jacek, Rutkowski, Piotr

“…Despite considerable progress made in the treatment of patients with advanced melanoma, the majority of the patients treated with BRAF and mitogen-activated…”
Get full text

NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay by Olbryt, Magdalena, Rajczykowski, Marcin, Bal, Wiesław, Fiszer-Kierzkowska, Anna, Cortez, Alexander Jorge, Mazur, Magdalena, Suwiński, Rafał, Widłak, Wiesława

“…Next-generation sequencing (NGS) in liquid biopsies may contribute to the diagnosis, monitoring, and personalized therapy of cancer through the real-time…”
Get full text

Quantitative analysis of plasma DNA in anal cancer patients by Małusecka, Ewa, Giglok, Monika, Suwiński, Rafał, Rutkowski, Tomasz, Mazurek, Agnieszka

“…Introduction The availability and non-invasiveness of circulating cell-free DNA (cfDNA) opens up new possibilities for real-time serial testing. The…”
Get full text

Circulating HPV16 DNA in Blood Plasma as Prognosticator and Early Indicator of Cancer Recurrence in Radio-Chemotherapy for Anal Cancer by Mazurek, Agnieszka M, Małusecka, Ewa, Jabłońska, Iwona, Vydra, Natalia, Rutkowski, Tomasz W, Giglok, Monika, Suwiński, Rafał

“…Implementation of anal squamous cell carcinoma (ASCC) treatment modifications requires reliable patient risk stratification. The circulating tumor-related…”
Get full text

Radiomic signature accurately predicts the risk of metastatic dissemination in late-stage non-small cell lung cancer by Wilk, Agata Małgorzata, Kozłowska, Emilia, Borys, Damian, D’Amico, Andrea, Fujarewicz, Krzysztof, Gorczewska, Izabela, Debosz-Suwinska, Iwona, Suwinski, Rafał, Smieja, Jarosław, Swierniak, Andrzej

Get full text

Development of immunity-related adverse events correlates with baseline clinical factors, survival and response to anti-PD-1 treatment in patients with inoperable or metastatic melanoma by Cybulska-Stopa, Bożena, Ziętek, Marcin, Czarnecka, Anna M., Piejko, Karolina, Dziura, Robert, Galus, Łukasz, Ziółkowska, Barbara, Kieszko, Stanisław, Kempa-Kamińska, Natasza, Calik, Jacek, Seredyńska, Joanna, Gądek, Kamila, Zemełka, Tomasz, Teterycz, Paweł, Kubiatowski, Tomasz, Suwiński, Rafał, Mackiewicz, Jacek, Rutkowski, Piotr

“…The relationship between immune related adverse events (irAEs) and efficacy is not definitively proven, and data on the relationship between irAE and treatment…”
Get full text

PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck by Snietura, Miroslaw, Jaworska, Magdalena, Mlynarczyk-Liszka, Joanna, Goraj-Zajac, Aleksandra, Piglowski, Wojciech, Lange, Dariusz, Wozniak, Grzegorz, Nowara, Elzbieta, Suwinski, Rafal

“…Tumor suppressor PTEN is known to control a variety of processes related to cell survival, proliferation, and growth. PTEN expression is considered as a…”
Get full text

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy by Cybulska-Stopa, Bożena, Ługowska, Iwona, Wiśniowski, Rafał, Domagała-Haduch, Małgorzata, Rajczykowski, Marcin, Piejko, Karolina, Bar-Letkiewicz, Ilona, Suwiński, Rafał, Regulski, Krzysztof, Mackiewicz, Jacek

“…Previous studies showed that high and low body mass index (BMI) was associated with worse prognosis in metastatic CRC (mCRC). Whether BMI is a prognostic or…”
Get full text

Pre-operative hyperfractionated concurrent radiochemotherapy for locally advanced rectal cancers: a phase II clinical study by Idasiak, Adam, Galwas-Kliber, Katarzyna, Behrendt, Katarzyna, Wziętek, Iwona, Kryj, Mariusz, Stobiecka, Ewa, Chmielik, Ewa, Suwiński, Rafał

“…The study was prospectively designed as a single-arm, single-institution prospective trial of pre-operative concomitant hyperfractionated radiotherapy (HART)…”
Get full text